"Abandoning medicine for chains" Hua Jian (01931) - Will ETHK become the next wealth-making myth or a vegetable harvesting machine?

IVD MEDICAL announced two major announcements on September 14th: first, the agreement with partner ETHK Group to jointly invest in and establish two new companies, ETHK Inc. and ETHK HOLDINGS LIMITED; second, a proposal to change the company's English name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and the Chinese bilingual name from "IVD MEDICAL Holdings Limited" to "". IVD MEDICAL's business focus is officially shifting towards in-depth research and global output of digital industry technology infrastructure, transforming from a medical enterprise to a builder of online financial ecosystems. IVD MEDICAL's "abandoning medicine for chains" strategy has sparked intense market debate: is this the beginning of disruptive innovation or another adventure in the world of capital games? I. Strategic Transformation: Abandoning medicine for chains, IVD MEDICAL's self-revolution IVD MEDICAL's strategic transformation is not a momentary impulse, but the culmination of a carefully planned series of actions. According to the announcement, the newly established ETHK Inc will focus on operating and developing the core brand "ETHK" to build a safe, efficient, compliant, and open decentralized financial platform. ETHK HOLDINGS LIMITED is positioned as the ecological-level digital industry investment and mergers central, with the strategic mainline of "completing the asset end, activating the fund end, and strengthening the compliance end", integrating industry entities, long-term funds, and licensed financial institutions globally. In line with the strategic transformation, IVD MEDICAL announced the upgrade of the original technical ecosystem domain name from ivd.xyz to labs.ethk.com, reflecting a fundamental shift in business focus from medical testing to digital technology infrastructure. The name "ETHK" is derived from the fusion of ETH - Ether and K - Kingdom, implying a new digital financial ecosystem built on the foundation of blockchain. II. Wealth Creation Myth: How ETHK empowers the globalization of Chinese assets The ETHK ecosystem created by IVD MEDICAL aims to become the high-speed highway for Chinese asset chain globalization, providing a platform for global capital to invest in high-quality assets. The strategic pillars of the ETHK ecosystem building strategy, as disclosed in the announcement, include: 1. Solid technological infrastructure: Compatible and deeply optimized for mainstream public chain ecosystems like Ethereum, while promoting independent research and development of high-performance blockchain underlying development and deployment. 2. Rich financial products and asset matrix: Comprehensive layout of money market basic assets, tokenization of real-world assets (RWA), with a focus on promoting the tokenization of equity assets including "on-chain stocks". 3. Sustainable business model and ecosystem incentives: Building diverse income models including transaction fees, asset issuance service fees, staking returns. 4. Global compliance and trust framework: Actively seeking relevant financial and payment licenses in major jurisdictions around the world, building a comprehensive financial licensing system. 5. Seamless user access and ultimate experience: Creating a unified user access, integrating fiat currency deposit and withdrawal channels, providing a simple and streamlined one-click operation experience. This ecosystem architecture directly addresses the pain points of current Chinese asset globalization: limited financing channels, insufficient international recognition, and low efficiency of cross-border flow. Through asset tokenization, ETHK can help high-quality Chinese assets "go online and international" in a compliant and standardized manner, enhancing international recognition and allocation efficiency. III. Strategic Elevation: The financial infrastructure that benefits the country, the people, and the world IVD MEDICAL's strategic upgrade is based on profound policy insights. Since 2025, the government has repeatedly issued policies to promote the marketization of intellectual property and innovation in science and technology finance. The ETHK strategy of IVD MEDICAL is a precise response to national policies. By empowering asset digitization through blockchain technology, especially tokenizing intellectual property assets, IVD MEDICAL is building a financial infrastructure in line with the country's strategic direction. Market data also supports the rationale for this transformation. According to the "RWA Industry Development Research Report" released by the Hong Kong Web3.0 Standardization Association, as of June 2025, the total lock-up volume (TVL) of RWA reached $12.5 billion, a 124% increase from 2024. Tokenized private credit dominates the market (58%), followed by tokenized US Treasury bonds (34%). Boston Consulting Group (BCG) and the Singapore Digital Exchange (ADDX) jointly predict that by 2030, the global RWA market size will reach $16.1 trillion, accounting for 10% of the global GDP. IVD MEDICAL's stock performance also reflects market recognition. Since the series of strategic transformations and upgrades initiated in July, the company's stock price has continued to rise, closing at $10.44 Hong Kong dollars on September 12th, compared to $2 on July 2nd, indicating investors' support and trust in this strategic direction. IVD MEDICAL's recent stock performance, source: East Money Information IV. Not harvesting leeks, but creating a new paradigm of value creation IVD MEDICAL's new positioning stems from thoughtful strategic choices. The altruistic value behind it is reflected at various levels: For the country, the ETHK ecosystem is the foundation infrastructure for Chinese assets to go global, enhancing China's international pricing power for assets and aiding the internationalization of the Renminbi. It also aligns with Hong Kong's strategic positioning to build an international digital financial center, responding to the policy orientation of Hong Kong's "Stablecoin Regulations" and the "Digital Asset Development Policy Declaration 2.0". For the industry, IVD MEDICAL lowers the threshold for asset digitization through technological empowerment, especially providing high-tech enterprises with new financing channels and value realization mechanisms, which may significantly shorten the research and commercialization cycles, accelerating the global benefits of high-tech products. For society, the ETHK ecosystem lowers the investment threshold through "fragmentation" technology, allowing ordinary investors to participate in top asset investments with less capital, embodying the concept of inclusive finance. For investors, IVD MEDICAL brings not only short-term stock price increases but also long-term opportunities to share the dividends of digital economic development. With holdings of 5,190 Ether (ETH) and a buying budget of 880 million Hong Kong dollars, the company provides investors with dual value anchors - stable cash flow from traditional medical business and the growth potential of digital assets. The Shanghai New World of online finance is unfolding before us, and IVD MEDICAL already has a first-class ticket.